Latest Medifast Inc (MED) Headlines Medifast (M
Post# of 18
Posted On: 03/14/2014 2:30:01 AM
Latest Medifast Inc (MED) Headlines
Medifast (MED) in Focus: Stock Moves 8.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:46AM CDT
Medifast was a big mover last session, with shares rising just over 8% on the day.
NYSE stocks posting largest volume increases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
NYSE stocks posting largest percentage increases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Why Shares of Medifast Inc. Jumped
Jeremy Bowman, The Motley Fool - Motley Fool - Tue Mar 11, 4:01PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Medifast Inc. were looking healthier...
Short Squeeze Staring on Medifast (MED)
M2 - Tue Mar 11, 9:37AM CDT
March 11, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Medifast (NYSE: MED). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $24.23 and the projected fundamental valuation of $39.72.
Medifast to expand into Canada in Q1 2014
M2 - Tue Mar 11, 6:54AM CDT
US-based Medifast Inc (NYSE:MED), a nutrition and weight-loss company, announced on Monday plans to expand its international presence by launching in Canada in Q1 2014.
Medifast, Inc. Announces Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Mon Mar 10, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today reported financial results for the fourth quarter and fiscal year ended December 31, 2013.
Medifast Announces Expansion into Canadian Market
PR Newswire - Mon Mar 10, 8:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of portion-controlled meal replacement products and programs, announced today that it will expand its international presence by launching in Canada in the first quarter of 2014. Initially, this expansion will take place through Medifast Direct, the company's e-commerce sales channel, and Medifast Medical Providers, a network of health care providers who, where available, will offer Medifast's program and products.
Medifast Board Member Barry Bondroff Honored As BBJ's Outstanding Director
PRWeb - Tue Mar 04, 3:32PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, is proud to announce that Barry Bondroff, Lead Director on Medifast's Board of Directors, has received the Baltimore Business Journal 2014 Outstanding Directors Award.
Medifast President & COO Meg Sheetz Named to The Daily Record's Top 100 Women List
PRWeb - Mon Mar 03, 3:32PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, is proud to announce that its President and Chief Operating Officer, Meg Sheetz, has been named to The Daily Record's 2014 list of Top 100 Women.
Medifast Recognized Among Top Companies on Chief Executive's 2014 Mid-Market Elite List
PR Newswire - Thu Feb 20, 3:59PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today announced that it has earned a position on the 2014 Mid-Market Elite list for Chief Executive magazine.
Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2013
PR Newswire - Wed Feb 12, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, will announce financial results for the fourth quarter and fiscal year ended December 31, 2013 on Monday, March 10, 2014, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Michael C. MacDonald, Executive Chairman and Chief Executive Officer, Timothy Robinson, Chief Financial Officer, and Margaret Sheetz, President and Chief Operating Officer.
Medifast Announces Partnership with The V Foundation for Cancer Research
PR Newswire - Tue Feb 11, 3:10PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs announced today its partnership with The V Foundation for Cancer Research, one of the nation's leading cancer research funding organizations. As part of this multi-faceted partnership with The V Foundation, Medifast will fund research grants that explore the link between obesity and cancer and the impact of healthy living on preventing cancer-related diseases.
One-Time Deep-Sixed Penny Stocks Now Thriving: Sirius XM Holdings Inc. (NASDAQ: SIRI), Medifast, Inc. (NYSE: MED), Axle & Manufacturing Holdings, Inc. (NYSE: AXL), Pier 1 Imports Inc. (NYSE: PIR).
ACCESSWIRE - Wed Feb 05, 10:27AM CST
Over the last 15 years, the economy has endured a bursting Internet bubble, a crashing housing and stock market - plus a deep-sixed auto industry.
Commit To Buy Medifast At $22, Earn 9.8% Annualized Using Options
StockOptionsChannel.com - Mon Jan 27, 10:41AM CST
Investors considering a purchase of Medifast shares, but cautious about paying the going market price of $26.52/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
Medifast Named a SmartCEO Future 50 Blue Chip Award Winner
PR Newswire - Mon Jan 27, 7:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today announced that it has been named a Future 50 Blue Chip Award Winner by SmartCEO magazine.
Medifast (MED) Shares Cross Above 200 DMA
MarketNewsVideo.com - Fri Jan 17, 3:07PM CST
In trading on Friday, shares of Medifast Inc crossed above their 200 day moving average of $26.20, changing hands as high as $26.36 per share. Medifast Inc shares are currently trading up about 1.6% on the day.
Recognitions, Updated Guidance, Cash Tender Offers, Stock Price Movements, and Store Sales - Research Report on Abercrombie & Fitch, Francesca's, Men's Wearhouse, Express, and Buckle
PR Newswire - Wed Jan 15, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
Medifast Partners With Usablenet on New Mobile Experience to Kick-Start Customers' New Year Resolutions
Marketwire - Mon Jan 13, 8:03AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, teamed up with technology provider Usablenet to launch its first mobile site. The new mobile site aims to assist health conscious customers on their weight management journey by providing easy access to products, guidelines, and recipes, anytime, anywhere from mobile devices. With many Medifast customers making purchases online, and a growing percentage of purchases already coming via mobile, Medifast has taken a solid step forward toward its goal of being a world-class e-commerce company. The new site features e-commerce-enabled product browsing and a large number of personalized weight-loss plans, which are optimized and easy to read on mobile devices.
Medifast (MED) in Focus: Stock Moves 8.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:46AM CDT
Medifast was a big mover last session, with shares rising just over 8% on the day.
NYSE stocks posting largest volume increases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
NYSE stocks posting largest percentage increases
AP - Tue Mar 11, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Why Shares of Medifast Inc. Jumped
Jeremy Bowman, The Motley Fool - Motley Fool - Tue Mar 11, 4:01PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Medifast Inc. were looking healthier...
Short Squeeze Staring on Medifast (MED)
M2 - Tue Mar 11, 9:37AM CDT
March 11, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on Medifast (NYSE: MED). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $24.23 and the projected fundamental valuation of $39.72.
Medifast to expand into Canada in Q1 2014
M2 - Tue Mar 11, 6:54AM CDT
US-based Medifast Inc (NYSE:MED), a nutrition and weight-loss company, announced on Monday plans to expand its international presence by launching in Canada in Q1 2014.
Medifast, Inc. Announces Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Mon Mar 10, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today reported financial results for the fourth quarter and fiscal year ended December 31, 2013.
Medifast Announces Expansion into Canadian Market
PR Newswire - Mon Mar 10, 8:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of portion-controlled meal replacement products and programs, announced today that it will expand its international presence by launching in Canada in the first quarter of 2014. Initially, this expansion will take place through Medifast Direct, the company's e-commerce sales channel, and Medifast Medical Providers, a network of health care providers who, where available, will offer Medifast's program and products.
Medifast Board Member Barry Bondroff Honored As BBJ's Outstanding Director
PRWeb - Tue Mar 04, 3:32PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, is proud to announce that Barry Bondroff, Lead Director on Medifast's Board of Directors, has received the Baltimore Business Journal 2014 Outstanding Directors Award.
Medifast President & COO Meg Sheetz Named to The Daily Record's Top 100 Women List
PRWeb - Mon Mar 03, 3:32PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, is proud to announce that its President and Chief Operating Officer, Meg Sheetz, has been named to The Daily Record's 2014 list of Top 100 Women.
Medifast Recognized Among Top Companies on Chief Executive's 2014 Mid-Market Elite List
PR Newswire - Thu Feb 20, 3:59PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today announced that it has earned a position on the 2014 Mid-Market Elite list for Chief Executive magazine.
Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2013
PR Newswire - Wed Feb 12, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, will announce financial results for the fourth quarter and fiscal year ended December 31, 2013 on Monday, March 10, 2014, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Michael C. MacDonald, Executive Chairman and Chief Executive Officer, Timothy Robinson, Chief Financial Officer, and Margaret Sheetz, President and Chief Operating Officer.
Medifast Announces Partnership with The V Foundation for Cancer Research
PR Newswire - Tue Feb 11, 3:10PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs announced today its partnership with The V Foundation for Cancer Research, one of the nation's leading cancer research funding organizations. As part of this multi-faceted partnership with The V Foundation, Medifast will fund research grants that explore the link between obesity and cancer and the impact of healthy living on preventing cancer-related diseases.
One-Time Deep-Sixed Penny Stocks Now Thriving: Sirius XM Holdings Inc. (NASDAQ: SIRI), Medifast, Inc. (NYSE: MED), Axle & Manufacturing Holdings, Inc. (NYSE: AXL), Pier 1 Imports Inc. (NYSE: PIR).
ACCESSWIRE - Wed Feb 05, 10:27AM CST
Over the last 15 years, the economy has endured a bursting Internet bubble, a crashing housing and stock market - plus a deep-sixed auto industry.
Commit To Buy Medifast At $22, Earn 9.8% Annualized Using Options
StockOptionsChannel.com - Mon Jan 27, 10:41AM CST
Investors considering a purchase of Medifast shares, but cautious about paying the going market price of $26.52/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in...
Medifast Named a SmartCEO Future 50 Blue Chip Award Winner
PR Newswire - Mon Jan 27, 7:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today announced that it has been named a Future 50 Blue Chip Award Winner by SmartCEO magazine.
Medifast (MED) Shares Cross Above 200 DMA
MarketNewsVideo.com - Fri Jan 17, 3:07PM CST
In trading on Friday, shares of Medifast Inc crossed above their 200 day moving average of $26.20, changing hands as high as $26.36 per share. Medifast Inc shares are currently trading up about 1.6% on the day.
Recognitions, Updated Guidance, Cash Tender Offers, Stock Price Movements, and Store Sales - Research Report on Abercrombie & Fitch, Francesca's, Men's Wearhouse, Express, and Buckle
PR Newswire - Wed Jan 15, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
Medifast Partners With Usablenet on New Mobile Experience to Kick-Start Customers' New Year Resolutions
Marketwire - Mon Jan 13, 8:03AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, teamed up with technology provider Usablenet to launch its first mobile site. The new mobile site aims to assist health conscious customers on their weight management journey by providing easy access to products, guidelines, and recipes, anytime, anywhere from mobile devices. With many Medifast customers making purchases online, and a growing percentage of purchases already coming via mobile, Medifast has taken a solid step forward toward its goal of being a world-class e-commerce company. The new site features e-commerce-enabled product browsing and a large number of personalized weight-loss plans, which are optimized and easy to read on mobile devices.
(0)
(0)Medifast Inc (MED) Stock Research Links
Scroll down for more posts ▼